Renalytix Plc (RENX.L)
GBp 9.5
(0.0%)
GBp 9.5
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 54.5 Billion EUR | 230225.83% |
| 2022 | 23.66 Million USD | 17.79% |
| 2021 | 20.08 Million USD | 168.71% |
| 2020 | 7.47 Million USD | 40.1% |
| 2019 | 5.33 Million USD | 606.75% |
| 2018 | 755 Thousand USD | 1043.68% |
| 2017 | 66.01 Thousand USD | -100.0% |
| 2016 | 41.52 Billion EUR | 5.56% |
| 2015 | 39.33 Billion EUR | -3.76% |
| 2014 | 40.86 Billion EUR | -3.33% |
| 2013 | 42.27 Billion EUR | 6.03% |
| 2012 | 39.87 Billion EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 FY | 54.5 Billion EUR | 230225.83% |
| 2023 Q2 | 19.2 Million USD | -8.67% |
| 2023 Q1 | 21.03 Million USD | -11.12% |
| 2022 Q3 | 21.7 Million USD | -0.32% |
| 2022 FY | 23.66 Million USD | 17.79% |
| 2022 Q1 | 19.87 Million USD | -1.09% |
| 2022 Q2 | 21.77 Million USD | 9.59% |
| 2022 Q4 | 23.66 Million USD | 9.02% |
| 2021 Q3 | 15.05 Million USD | 75.89% |
| 2021 Q2 | 8.55 Million USD | 17.35% |
| 2021 Q1 | 7.29 Million USD | -2.46% |
| 2021 FY | 20.08 Million USD | 168.71% |
| 2021 Q4 | 20.08 Million USD | 33.47% |
| 2020 Q4 | 7.47 Million USD | 40.47% |
| 2020 Q2 | 4.11 Million USD | 1.03% |
| 2020 Q1 | 4.07 Million USD | -23.61% |
| 2020 FY | 7.47 Million USD | 40.1% |
| 2020 Q3 | 5.32 Million USD | 29.24% |
| 2019 FY | 5.33 Million USD | 606.75% |
| 2019 Q1 | 55.5 Billion EUR | 7351514.19% |
| 2019 Q2 | 1.3 Million USD | -100.0% |
| 2019 Q3 | 57.47 Billion EUR | 4407592.17% |
| 2019 Q4 | 5.33 Million USD | -99.99% |
| 2018 Q1 | 56.87 Billion EUR | -4.27% |
| 2018 Q2 | 809 Thousand USD | -100.0% |
| 2018 Q4 | 755 Thousand USD | -100.0% |
| 2018 Q3 | 57.35 Billion EUR | 7089657.89% |
| 2018 FY | 755 Thousand USD | 1043.68% |
| 2017 Q1 | 54.24 Billion EUR | 15.31% |
| 2017 Q3 | 62.67 Billion EUR | 9.15% |
| 2017 Q2 | 57.42 Billion EUR | 5.85% |
| 2017 FY | 66.01 Thousand USD | -100.0% |
| 2017 Q4 | 59.41 Billion EUR | -5.21% |
| 2016 Q1 | 44.31 Billion EUR | 2.13% |
| 2016 Q4 | 47.04 Billion EUR | 7.06% |
| 2016 Q3 | 43.94 Billion EUR | 5.83% |
| 2016 Q2 | 41.52 Billion EUR | -6.3% |
| 2016 FY | 41.52 Billion EUR | 5.56% |
| 2015 FY | 39.33 Billion EUR | -3.76% |
| 2015 Q3 | 44.49 Billion EUR | 13.12% |
| 2015 Q2 | 39.33 Billion EUR | -2.68% |
| 2015 Q4 | 43.38 Billion EUR | -2.49% |
| 2015 Q1 | 40.41 Billion EUR | -3.24% |
| 2014 Q1 | 42.61 Billion EUR | -9.39% |
| 2014 Q4 | 41.77 Billion EUR | 3.69% |
| 2014 Q3 | 40.28 Billion EUR | -1.42% |
| 2014 Q2 | 40.86 Billion EUR | -4.09% |
| 2014 FY | 40.86 Billion EUR | -3.33% |
| 2013 Q4 | 47.02 Billion EUR | -0.64% |
| 2013 FY | 42.27 Billion EUR | 6.03% |
| 2013 Q3 | 47.33 Billion EUR | 11.96% |
| 2013 Q2 | 42.27 Billion EUR | 1.75% |
| 2013 Q1 | 41.54 Billion EUR | -10.67% |
| 2012 FY | 39.87 Billion EUR | 0.0% |
| 2012 Q1 | 38.83 Billion EUR | 0.0% |
| 2012 Q4 | 46.5 Billion EUR | 1.46% |
| 2012 Q3 | 45.84 Billion EUR | 14.98% |
| 2012 Q2 | 39.87 Billion EUR | 2.66% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|